Feng Yin

Statistics

Publications

Citations

282

H-Index

Active since

2014

Affiliations

First Affiliated Hospital of Henan University of Science and Technology(Current)

Feng Yin is an author at First Affiliated Hospital of Henan University of Science and Technology specializing in cancer progression, microrna in cancer, and molecular oncology.

ORCID

Publications per year

2014–2021

Publications

Silver-Mediated Radical Aryltrifluoromethylthiolaton of Activated Alkenes

Feng Yin, Xi‐Sheng Wang · Organic Letters · 2014 · 201 citations

Natural Sciences, Chemistry, Catalysis +12

<p>LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer</p>

Feng Yin, Qian Zhang, Zhihui Dong et al. · OncoTargets and Therapy · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +15

SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics

Benhong Xu, Yuxuan Lei, Xiaohu Ren et al. · ACS Omega · 2021 · 20 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

miR-141-3p suppresses development of clear cell renal cell carcinoma by regulating NEK6

Yifei Liu, Wenqiang Fu, Feng Yin et al. · Anti-Cancer Drugs · 2021 · 17 citations

Medicine, Cancer Biology, Oncology +17

1–4 of 4